story of the week
De-Escalation of Adjuvant Endocrine Therapy in Patients With ER-Low–Positive Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
De-escalation of five-year adjuvant endocrine therapy in patients with estrogen receptor-low positive (immunohistochemistry staining 1%-10%) breast cancer: Propensity-matched analysis from a prospectively maintained cohort
Cancer 2022 Feb 25;[EPub Ahead of Print], YW Cai, ZM Shao, KD YuFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.